Baird initiates coverage on EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT) with a ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

New Coverage

EyePoint Pharmaceuticals (EYPT) shares surge as Baird says there are 'multiple catalysts ahead'April 21, 2023 1:50 PM EyePoint Pharmaceuticals (EYPT) Halted on Volatility, Up 67%April 21, 2023 10:19 AM EyePoint Pharmaceuticals (EYPT) Climbs 38% Following Outperform RatingApril 21, 2023 10:15 AM